Drug General Information
Drug ID
D06TEO
Former ID
DNC001483
Drug Name
UCL-1390
Drug Type
Small molecular drug
Indication Eating disorder; Epilepsy; Pain [ICD9: 307.5, 338,780; ICD10:F50, R52, G89] Terminated [545875]
Therapeutic Class
Analgesics
Company
University College London
Structure
Download
2D MOL

3D MOL

Formula
C13H13N3O
Canonical SMILES
C1=CC(=CC=C1C#N)OCCCC2=CN=CN2
InChI
1S/C13H13N3O/c14-8-11-3-5-13(6-4-11)17-7-1-2-12-9-15-10-16-12/h3-6,9-10H,1-2,7H2,(H,15,16)
InChIKey
XQNBJFUWFIHAMW-UHFFFAOYSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Histamine H3 receptor Target Info Antagonist [536225]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome Histamine receptors
G alpha (i) signalling events
WikiPathways Monoamine Transport
GPCRs, Class A Rhodopsin-like
GPCR ligand binding
GPCR downstream signaling
References
Ref 545875Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005172)
Ref 536225Emerging drugs for eating disorder treatment. Expert Opin Emerg Drugs. 2006 May;11(2):315-36.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.